Status:
ENROLLING_BY_INVITATION
Obstructive Sleep Apnea and Biomarkers of Alzheimer's Disease
Lead Sponsor:
Alberto Alonso Fernandez
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Clinical trial on the effect of continuous positive pressure (CPAP). Objectives: 1) To compare biomarkers of Alzheimer's disease in plasma samples from patients with Obstructive sleep apnea (OSA) and ...
Detailed Description
Randomized, parallel group, non-blinded, controlled clinical trial compared with conventional treatment. A. Protocol and intervention Patients with an Apnea-Hypopnea index (AHI)\>30 h-1 will be assig...
Eligibility Criteria
Inclusion
- Cases: patients with AHI \> 30/h
- Controls: subjects with AHI \< 5/h and Epworth \<10
Exclusion
- Epworth\>18
- BMI\<40Kg/M2
- Arterial Hypertension
- Diabetes Mellitus
- Cerebrovascular disease
- Ischemic heart disease
- Cardiac arrhythmia
- Chronic cardiovascular diseases
- Daytime Oxygen saturation\>95%
- Risk professions (professional drivers)
- Concomitant treatment with antihypertensives, statins, antidiabetics, beta- blockers or systemic corticosteroids.
- Pretreatment with CPAP.
- Participation in another clinical trial thirty days prior to randomization
- Abnormal values of a cognitive test.
Key Trial Info
Start Date :
July 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 6 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04905238
Start Date
July 31 2020
End Date
May 6 2025
Last Update
May 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Son Espases
Palma, Balearic Islands, Spain, 07006
2
Hospital Son Llatzer
Palma, Balearic Islands, Spain, 07006